Back to Results
First PageMeta Content
Anatomy / T-cell receptor / Immunotherapy / Melanoma / Cancer / Linker of activated T cells / Lymphocyte / T cells / Biology / Medicine


Affinity Optimized NY-ES0-1 and MAGE-A3/6 Specific T Cells for Melanoma Protocol #[removed]Phase I Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells Against Cancer-Testis Antigens In
Add to Reading List

Document Date: 2013-12-31 13:23:50

Open Document

File Size: 1,31 MB

Share Result on Facebook

Company

Ligand / Ph.D. Adaptimmune Ltd. / /

Event

FDA Phase / /

Facility

University of Pennsylvania / University School / /

MedicalCondition

Tumor / Melanoma / Ovarian cancer / Lung cancer / Cancer / tumors / disease / CTLs cancer / enhanced TCRs kill cancer / T cells Cancer / Cutaneous Melanoma / metastasis / /

MedicalTreatment

gene therapy / cell therapy / surgery / immunotherapy / /

Organization

Washington University School of Medicine / University of Pennsylvania / /

Person

Bent Jakobsen / Carl June / Gerald P. Linette / /

Position

STUDY CHAIR / Principal Investigator / /

Product

Dacarbazine / A3 / /

ProvinceOrState

Pennsylvania / /

Technology

gene therapy / Melanoma Protocol / cell therapy / Cell Therapy Protocol / 2 Protocol / /

URL

http /

SocialTag